Manufacturing / Pharmaceutical Preparations
Spyre Therapeutics, Inc.
SYRE
$85.41
+$5.81 (+7.28%)
Price as of Oct 9, 2026 19:55 UTC
9.4 B
Market Cap (Mid Cap)
Nov 02
Next Earnings
Technical Signals
as of Oct 7
Bearish
2 of 7
Trend
- Above 20-day average $88.69
- Above 50-day average $91.09
- Above 200-day average $68.60 · +17.9%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 19d ago
Volume
- Elevated volume 1.9x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for SYRE options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
97 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 01, 2026 | King-Jones Heidy | Sell | 16,605 | $1,500,262 | -11.6% | |
| Oct 01, 2026 | King-Jones Heidy | Exercise | 28,933 | $419,529 | +451.0% | |
| Oct 01, 2026 | Turtle Cameron | Sell | 3,989 | $368,225 | -13.4% | |
| Oct 01, 2026 | Burrows Scott L | Sell | 2,100 | $193,032 | -13.1% | |
| Oct 01, 2026 | King-Jones Heidy | Sell | 2,600 | $242,996 | -14.5% | |
| Oct 01, 2026 | King-Jones Heidy | Sell | 2,100 | $194,670 | -13.8% | |
| Oct 01, 2026 | Turtle Cameron | Sell | 4,990 | $465,916 | -14.4% | |
| Oct 01, 2026 | Turtle Cameron | Sell | 2,638 | $241,351 | -12.7% | |
| Oct 01, 2026 | Turtle Cameron | Sell | 2,683 | $241,738 | -11.3% | |
| Oct 01, 2026 | Turtle Cameron | Sell | 600 | $53,484 | -10.4% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 06, 2026 | Q2 2026 | -$0.77 | |||
| Aug 03, 2026 | Q2 2026 | -$0.77 | |||
| Jun 30, 2026 | Q2 2026 | -$0.77 | -$0.36 | +53.5% | Beat |
| Mar 31, 2026 | Q1 2026 | -$0.68 | -$0.74 | -8.9% | Miss |
| Dec 31, 2025 | Q4 2025 | -$0.79 | -$0.70 | +11.4% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.76 | -$0.15 | +80.3% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.77 | -$0.77 | -0.2% | Miss |
Track SYRE with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SYRE and your entire portfolio.